Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Rocket Pharmaceuticals (RCKT) Return on Sales (2018 - 2025)

Historic Return on Sales for Rocket Pharmaceuticals (RCKT) over the last 2 years, with Q3 2017 value amounting to 17.51%.

  • Rocket Pharmaceuticals' Return on Sales fell 36900.0% to 17.51% in Q3 2017 from the same period last year, while for Sep 2017 it was 17.51%, marking a year-over-year change of. This contributed to the annual value of 17.51% for FY2015, which is 86500.0% up from last year.
  • Rocket Pharmaceuticals' Return on Sales amounted to 17.51% in Q3 2017, which was down 36900.0% from 42.49% recorded in Q4 2016.
  • In the past 5 years, Rocket Pharmaceuticals' Return on Sales ranged from a high of 49.17% in Q1 2016 and a low of 17.51% during Q3 2017